Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG

Jasper G. van den Boorn, Debby Konijnenberg, Esther P. M. Tjin et al. · 2010

Read Effective Melanoma Immunotherapy in Mice by the Skin-Depigmenting Agent Monobenzone and the Adjuvants Imiquimod and CpG by Jasper G. van den Boorn, Debby Konijnenberg, Esther P. M. Tjin et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010626.txt.

Description

Jasper van den Boorn and colleagues combined three treatments against melanoma in mice, in PLOS ONE in 2010. Melanoma that has spread is hard to treat with standard drugs. Yet the cancer is visible to the immune system, which gives immunotherapy a chance.

One drug, monobenzone, removes skin pigment and exposes pigment cells to attack. Two helper compounds, imiquimod and CpG, then rally immune cells. Together the trio shrank tumors and extended survival in the mice. Turning the pigment system into a target may offer a new route for patients who run out of options.

Catalog record

CREATORJasper G. van den Boorn, Debby Konijnenberg, Esther P. M. Tjin et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010626

Browse the full library · About the Tower of Babel